Clinical Trials Logo

Clinical Trial Summary

This study compares the effects of Avandamet (rosiglitazone maleate/metformin) treatment and metformin plus sulphonylurea treatment in overweight people with type 2 diabetes.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00359112
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 3
Start date February 2004

See also
  Status Clinical Trial Phase
Completed NCT00231387 - Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus Phase 3
Completed NCT00318656 - 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes Phase 4
Terminated NCT01582282 - Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects Phase 4
Not yet recruiting NCT06401733 - Intensive Aerobic and Resistance Exercise Program (IAREP) N/A
Completed NCT02722499 - Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST) N/A
Completed NCT01472328 - Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes N/A
Completed NCT00269061 - Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin Phase 1
Completed NCT00291356 - GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients Phase 2
Completed NCT00825383 - Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM) N/A
Completed NCT00156897 - Efficacy and Safety of ATL-962 in Obese Diabetics Phase 2